We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shire Pharmaceuticals has agreed to drop a lawsuit against Barr Laboratories as part of a patent settlement involving Shire’s extended-release attention-deficit/hyperactivity disorder drug Adderall XR, the companies said Aug. 14.